SFI
TRIB

Susquehanna Fundamental Investments’s Trinity Biotech TRIB Stock Holding History

Susquehanna Fundamental Investments’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-223
Closed -$98K – 1897
2021
Q2 		$98K Hold
223
– – ﹤0.01% 1571
2021
Q1 		$126K Hold
223
– – ﹤0.01% 1447
2020
Q4 		$127K Sell
223
-104
-32% -$51.6K ﹤0.01% 1402
2020
Q3 		$99K Buy
+327
New +$114K ﹤0.01% 1284

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna Fundamental Investments's TRIB Position: Q3 2021 in Review

Susquehanna Fundamental Investments sold out of Trinity Biotech (TRIB) in Q3 2021, closing a stake of 223 shares — an estimated $98K sold.

Susquehanna Fundamental Investments first reported a position in TRIB in Q3 2020 and held it in 4 quarters. The position peaked at $127K in Q4 2020. 21 funds tracked by Wall St. Rank hold TRIB as of Q3 2021.

  • Susquehanna Fundamental Investments reported no remaining Trinity Biotech position as of Q3 2021 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 223 Trinity Biotech shares in Q3 2021, an estimated $98K.
  • Susquehanna Fundamental Investments first reported a position in Trinity Biotech in Q3 2020 and held it in 4 quarters.
  • Susquehanna Fundamental Investments's Trinity Biotech position peaked at $127K in Q4 2020.
  • 21 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q3 2021, filed 15 Nov 2021.